Coral Genomics
New clinical tests for managing autoimmune treatments.
已被收购
公司介绍
公司介绍（英文）
Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases.
We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.
主题
- 团队规模
- 5 名员工
- YC 批次
- Summer 2018
- 状态
- 已被收购
- 阶段
- 早期阶段
